RCI Hospitality, Quantum Computing, Teva Pharmaceutical, Tesla And Other Big Stocks Moving Higher On Monday

U.S. stocks were mostly higher, with the Nasdaq Composite gaining around 1% on Monday.

Shares of RCI Hospitality Holdings, Inc. RICK rose sharply during Tuesday's session after the company reported better-than-expected quarterly financial results.

RCI Hospitality reported quarterly earnings of $1.63 per share which beat the analyst consensus estimate of 37 cents per share. The company reported quarterly sales of $73.23 million which beat the analyst consensus estimate of $72.98 million.

RCI Hospitality shares surged 15.4% to $60.16 on Tuesday.

Here are some other big stocks recording gains in today's session.

  • Quantum Computing Inc. QUBT shares jumped 31.7% to $14.60 after the company announced it was awarded a prime contract by NASA to apply Dirac-3 for imaging and data processing support.
  • Akso Health Group AHG shares surged 25.6% to $1.47.
  • Arqit Quantum Inc. ARQQ shares gained 21.7% to $32.20.
  • Teva Pharmaceutical Industries Limited TEVA climbed 20% to $19.82 after the company and Sanofi announced that primary endpoints were met in the Phase 2b trial of Duvakitug for ulcerative colitis and Crohn’s disease.
  • Hesai Group HSAI gained 20% to $12.16.
  • Jupiter Neurosciences, Inc. JUNS gained 17.8% to $12.10.
  • SelectQuote, Inc. SLQT shares rose 17.3% to $3.2388.
  • Rezolve AI Limited RZLV gained 15% to $2.4494.
  • Arqit Quantum Inc. ARQQ rose 15% to $30.39.
  • SkyWater Technology, Inc. SKYT gained 14.2% to $11.60.
  • Rigetti Computing, Inc. RGTI gained 11.3% to $9.38.
  • GameStop Corp. GME gained 5.3% to $31.01.
  • Bilibili Inc. BILI rose 5% to $20.17.
  • Sanofi SNY gained 4.8% to $48.08 after the company and Teva announced that primary endpoints were met in the Phase 2b trial of Duvakitug for ulcerative colitis and Crohn’s disease.
  • Tesla, Inc. TSLA shares rose 3% to $477.19 after Mizuho upgraded the stock from Neutral to Outperform and raised its price target from $230 to $515.

Now Read This:

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!